WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.19, ss.385-390, 2015 (ESCI)
Aim of the study: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.